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The purpose of this study was to investigate the 
relationship between response to Rapid Induction Anal-
gesia (RIA) and certain characteristics of the chronic 
pain patient. Specifically, the effects of RIA on clini-
cal and experimental pain were compared to the effects of 
an oral placebo on clinical and experimental pain in 30 
volunteer paraplegic patients with chronic pain. Hyp-
notic susceptibility and chronic pain experience were 
also correlated with the effects of RIA on clinical and 
experimental pain. 
Definition of Chronic Pain 
Chronic pain is defined as pain of six months or 
more duration. It may either accompany an ongoing dis-
ease process, such as cancer, or a stabilized medical 
condition, such as spinal cord injury. Chronic pain 
which accompanies a stabilized medical condition is re-
ferred to as benign. 
The Need for Research on Chronic Pain 
Pain is the most common symptom that compels pa-
tients to seek medical attention (Bonica, 1974). As a 
disabling disease, chronic pain constitutes a serious 
world health and economic problem. Unlike acute pain, 
chronic benign pain serves neither as a warning signal 
nor as a diagnostic aid. Medical approaches which sue-
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cessfully alleviate acute pain (e.g., chemical and/or 
surgical intervention) frequently fail to manage chronic 
pain and may produce narcotic addiction and/or mutila-
tion. Chronic pain syndromes often impose severe emo-
tional, physical, and economic stress on patients, fam-
ilies, and society for long periods of time. 
Chronic pain patients bring a complex mixture of 
psychological factors, motivational factors, and past 
experience to the treatment situation. Unlike their 
acute counterparts (for whom pain may be a warning 
signal), they cannot ascribe meaning to the pain, with 
the result that they are subject to a variety of psycho-
logical consequences including irritability, anxiety, 
and depression (Sternbach, 1974). Reported studies of 
chronic pain patients support the premise that pain ex-
perienced over a prolonged period of time is accompanied 
by negative personality changes (Sternbach, Murphy, 
Akeson, & Wolf, 1973; Wolff & Wolf, 1958; Woodforde & 
Merskey, 1972). Chronic pain patients may use their 
pain in the service of interpersonal needs or they may 
be rewarded for hurting, as in the receipt of insurance 
compensation payments. Often, they have experienced 
many unsuccessful attempts to alleviate the pain. 
The investigation of mechanisms and management of 
chronic pain, as a valid research area distinct from 
that of acute pain, is relatively new (Bonica, 1974) 
Interest in the basic neurological mechanisms, the 
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development of animal models, and the clinical application 
of management techniques for chronic pain syndromes has 
recently grown, culminating in the first multidisciplinary 
International Symposium on Pain which convened in 1973. 
The Role of Psychology in the Field of Chronic Pain 
Approaches which would not be viable in the manage-
ment of acute pain may constitute the treatment of choice 
for chronic pain. It is an area in which psychologists 
are making a significant contribution. In both the ap-
plication and evaluation of treatment strategies psycho-
logists are uniquely suited. Not only does their train-
ing enable them to confront chronic pain syndromes in the 
context of dealing with the total person and problems of 
living, but it enables them to scientifically evaluate 
the efficacy of various treatment methods. Psychologists 
and other professionals currently use behavior modifi-
cation, hypnosis, autogenic training, and transcutaneous 
stimulation, in combination or separately, in chronic 
pain treatment clinics throughout the United States. 
Much of the psychological research regarding chron-
ic pain syndromes has been limited to psychogenic pain, 
while the .hreatment and investigation of pain with a 
clear organic etiology has been relegated to medicine. 
Nevertheless, the application of hypnotic analgesia to 
somatogenic pain is generally more appropriate than its 
application to psychogenic pain, where the pain may serve 
an an important coping mechanism (Orne, 1974). 
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Rapid Induction Analgesia (RIA) 
The clinical use of hypnosis to control pain has 
traditionally been limited, in part, because of the 
widely-held view (T. Barber, 1963) that hypnosis is in-
effective as an analgesic in most people. In fact, the 
amount by which pain is reduced through suggestions of 
analgesia consistently correlates with hypnotic sus-
ceptibility (Evans & Paul, 1970; Gottfredson, 1973; 
Hilgard, 1967; McGlashan, Evans & Orne, 1969; Shor, 1959}. 
Therefore, the probability of successful pain reduction 
through suggestions of analgesia is high (but not certain) 
only for those who are highly susceptible to hypnosis 
(Hilgard & Hilgard, 1975). 
Nevertheless, Joseph Barber (1976, 1977) concludes 
that hypnotic analgesia might be much more widely appli-
cable than previously believed. He derives this con-
clusion from his work with a technique to rapidly induce 
a state of hypnotic analgesia which he refers to as Rapid 
Induction Analgesia (RIA). This technique is based on 
Milton Erickson's indirect approach (Erickson, 1964; 
Erickson & Erickson, 1941; Erickson, Hershman & Sector; 
Erickson, Rossi & Rossi, 1976). It differs most strik-
ingly from the more direct hypnotic techniques used in 
previous studies of hypnotic analgesia in that the anal-
gesic suggestions are always indirectly framed in a post-
hypnotic context. 
Using the RIA: technique, Mayer, Price, J. Barber, 
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& Rafii (1976) effectively controlled experimental dental 
pain (electrical tooth pulp stimulation) up to an arbi-
trarily defined limit of 340 volts in 27 out of 27 vol-
unteer Ss. Using RIA, J. Barber (19771 effectively con-
trolled clinical dental pain (for fillings, root canal 
treatments, crown preparations, and extractions) in 99 
out of 100 patients. In both of these studies the "ef-
fective control" of pain was defined in terms of increa-
sing pain threshold or preventing the experience of pain; 
126 out of 127 Ss did not indicate any experience of 
dental pain following RIA. These results paired with 
J. Barbe~'s (1976) finding that the effectiveness of RIA 
is unrelated to hypnotic susceptibility suggest that hyp-
notic analgesia produced by "rapid induction" is univer-
sally effective in the control of dental pain regardless 
of hypnotic susceptibility. 
Since RIA had only been applied to dental pain, its 
effectiveness in controlling other types of clinical and 
experimental pain needed to be investigated. Its appli-
cability to chronic pain syndromes was of particular in-
terest because of the frequent failure of chemical and/or 
surgical approaches to manage pain in these cases. 
To investigate the effectiveness of RIA in control-
ling chronic pain syndromes the present s.tudy evaluated 
its effect on clinical pain, as measured by the subjec-
tively rated "Pain Estimate" (Sternbach, 1974)., and on 
experimental pain, as measured by time to pain threshold 
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and time to maximum pain tolerance during a modified 
Submaximum Effort Tourniquet Test, in 30 volunteer para-
plegic patients with chronic pain. Although the effects 
of RIA on clinical and experimental pain were expected 
to be consistent, it was desirable to include both, be-
cause subjective pain ratings may readily be affected by 
response bias and compliance (Evans, 1974). 
Unlike the previous studies which investigated the 
effect of RIA in preventing the experience of pain, the 
present study evaluated the effect of this technique on 
suprathreshold clinical and experimental pain. This is 
a better test of the applicability of RIA because it more 
closely resembles the clinical situation of pain manage-
ment and because threshold measures "have been notori-
ously unreliable, and are prone to the response bias 
inherent in subjective reports, particularly when it is 
clear to the S what is ... expected and desired ... " 
(Evans, 1974). In addition, it was necessary to obtain 
measures of hypnotic susceptibility, placebo response, 
and chronic pain experience for each Sin order to assess 
the relationship between these variables and response to 
RIA. 
To insure that results obtained using RIA were not 
the product of a particularly fortuitous sample (.e.g., 
one in which all Ss are highly susceptible), it was im-
perative to measure hypnotic susceptibility. Hilgard & 
Hilgard (.19.75) . repeatedly criticize authors who draw con-
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clusions about hypnosis on the basis of studies which 
failed to measure the hypnotic susceptibility of the S 
sample. Hypnotic susceptibility was measured with the 
revised Stanford Profile Scales of Hypnotic Suscepti-
bility: Form II (SPSHS: II} (Weitzenhoffer & Hilgardr 
1967). 
The effects of an oral placebo on clinical and ex-
perimental pain were measured using changes in the clini-
cal "Pain Estimate" (Sternbach, 1974); time to pain thres-
hold and time to maximum pain tolerance on the Tourniquet 
Test, respectively. Previous research has demonstrated 
that placebo analgesia is not related to secondary sug-
gestibility, or situational anxiety (Evans, 1967, 1969, 
1974; Hilgard & Hilgard, 1975). 
Evaluating chronic pain experience involves not 
only gathering information about the sensory and inten-
sity qualities of the experience, but also assessing the 
individual's emotional reaction to the pain. Chronic pain 
experience was measured by the McGill Pain Questionnaire. 
Scores on this variable typically distinguish . chronic 
pain patients from the ne.rmal population. Clinical ex-
perience led the author to believe that chronic pain ex-
perience would be related to the effects of RIA. 
Hypotheses to Be Tested 
There were four hypotheses to be tested. The first 
two hypotheses were logical implications derived from 
Joseph Barber's results in applying RIA to dental pain. 
8 
The third and fourth were based on the author's clinical 
experience. 
Hypothesis 1. RIA is significantly more effective 
than an oral placebo in (a) reducing clinical pain, and 
Cb) increasing experimental pain tolerance when the ef-
fects of hypnotic susceptibility and chronic pain experi-
ence are controlled. 
Hypothesis 2. The effect of RIA on (a) clinical 
pain and (b) experimental pain is not significantly re-
lated to hypnotic susceptibility when the effect of 
chronic pain experience is controlled. 
Hypothesis 3. Differences between the effect of RIA 
and the effect of an oral placebo on clinical pain are not 
constant for different levels of pre-treatment clinical 
Pain Estimates when the effects of hypnotic suscepti-
bility and chronic pain experience are controlled. 
Hypothesis 4. The effect of RIA on (a) clinical 
pain and (b) experimental pain is significantly related 
to chronic pain experience when the effect of hypnotic 
susceptibility is controlled. 
METHOD 
Selection of Subjects 
A review of the research literature on pain reveals 
that conclusions are frequently based on studies done with 
samples of individuals who have acute pain or who were 
subjected to short-term experimental pain in the absence 
of clinical pain. Attempts to generalize the results of 
these studies to chronic pain syndromes are highly ques-
tionable, because acute and experimental pain situations 
are not analogous to chronic pain in their emotional and 
physiological impact. It is therefore essential that 
investigations involving the management of chronic benign 
pain be accomplished by sampling from a chronic benign 
pain population. (Chronic benign pain is here defined as 
pain of six months or more duration, where there is no 
active disease process.) The present study selected 
spinal cord injured (SCI) patients because their pain is 
organic in origin, usually resulting from scarring of 
neural tissue. 
The Ss consisted of 30 male volunteer SCI paraplegic 
veterans with chronic pain syndrome. They ranged in age 
from 23 to 79 and in duration of pain from six months to 
34 years. The Ss were recruited through the SCI Service 
at Long Beach Veterans Administration Hospital (LBVAH), 
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Long Beach, California. They included both inpatients 
and outpatients who complained of SCI pain. Initial 
contact was through self-referral or physician referral 
to the SCI Pain Clinic, or in response to an ad in the 
Paralyzed Veterans' Bulletin for paraplegics with pain 
of six months or more duration. It was made clear that 
whether or not the individual participated in/ or com-
pleted the study, he would be offered a pain management 
program. 
Ss were medically evaluated for the study to elim-
inate candidates with a recent history of cardiovascular 
problems. In addition to the 30 ~s who completed the 
study, two candidates were eliminated because of cardio-
vascular problems and one~ did not complete the study. 
History and physical examination. Each S was 
interviewed by a physician to obtain a medical history 
focusing on his cardiovascular system. In addition, he 
was given a physical examination including a Rumpel-Leede 
Test of capillary fragility. Any~ whose physical con-
dition might conceivably be compromised by the Tourniquet 
Test, or who was currently under treatment for psychosis 
or severely brain damaged was excluded. 
Measurement 
The variables pertaining to the hypotheses to be 
tested were measured using the following instruments: 
the "Pain Estimate" (Sternbach, 1974); the modified 
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Submaximum Effort Tourniquet Test; the revised Stanford 
Profile Scales of Hypnotic Susceptibility: Form II 
(SPSHS: II) (Weitzenhoffer & Hilgard, 1967); and the 
McGill Pain Questionnaire (Melzack, 1975). 
The "Pain Estimate'' (Sternbach, 1974). Quantifi-
cation of pain is important in evaluating the extent of 
patients' suffering and the effect of various treatment 
modalities on pain. Most often the patient describes 
pain in terms of its character and expresses its inten-
sity in non-numerical values, which makes assessment 
difficult, if not impossible. 
In the inpatient Pain Unit of San Diego Veterans 
Administration Hospital, patients are routinely asked 
to rate the intensity of their pain on a scale of 0-100 
in which "0 is no pain at all, and 100 is pain so severe 
you'd commit suicide if you had to endure it more than 
a minute or two" (Sternbach, Murphy, Timmermans, Green-
hoot, & Akeson, 1974). The ~•s rating on this 0-100 
scale constitutes the "Pain Estimate." 
Aside from good face validity, Sternbach reports 
dramatic reductions in the Pain Estimate following treat-
ment interventions. Boswell (personal communication, 
1978) has computed one hour test-retest reliability of 
r=.97 (N=66) for SCI chronic pain patients. 
This measure was selected for use in the present 
study because it is easy for patients to understand and 
12 
work with, it is quickly made, and it is sensitive to 
change. 
The pre- and post-treatment clinical Pain Esti-
mates obtained for Sessions B (RIA) and C (placebo) 
constitute the data from which the effect of RIA and 
of placebo medication on clinical pain was calculated. 
The modified Submaximum Effort Tourniquet Test. To 
overcome the difficulties inherent in subjective pain 
scales, attempts have been made by several researchers 
to develop objective pain scales. The production of 
ischemic muscle pain (IMP) as an objective measure of 
pain was originally developed by Lewis (1929) at the 
University College Hospital in London. He felt that 
an objective pain test was critical for accurate diag-
nosis and understanding of the mechanisms of pain. In 
more recent years several investigators have continued 
to develop and use this measurement method (Caldwell & 
Smith, 1966; Dorpat & Holmes, 1955). The Submaximum 
Effort Tourniquet Test represents the most recent modi-
fication of this technique (Smith, Egbert, Markowitz, 
Mosteller, & Beecher, 1966; Smith, Lowenstein, Hubbard, 
& Beecher, 1968; Smith & Beecher, 1969). 
Ischernic muscle pain (IMP) is that pain which is 
experienced when blood flow to a limb is occluded and 
develops more rapidly when the limb is exercised. In 
early research IMP was produced by occluding blood flow 
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and sustaining a contraction strength of 11 cm. mercury 
(Hg), by squeezing a rubber bulb, attached by rubber 
tubing to a mercury manometer. On the average, pain 
first developed at 32 seconds and became intolerable at 
130 seconds. The maximum length of contraction was lim-
ited to 150 seconds at which point the contraction ampli-
tude involuntarily fell. The pain produced is deep, dull, 
and diffuse, increasing steadily in intensity as the test 
proceeds. When circulation to the limb is re-established, 
the pain vanishes completely in three to five seconds. 
The apparatus for the Tourniquet Test includes: 
(a) a Vantage sphygmomanometer, (b) a Baumanometer with 
a 300 mm. vertical Hg column, (c) a Rustrak four channel 
event recorder, (d) three Gerbrand cumulative recorders, 
and (e) a Semiconductor 24 volt D.C. power supply. The 
Baumanometer has four insulated copper wires inserted 
into the Hg column with barred tips of 2 mm. The common 
wire extends the full length of the Hg column. Barred 
tips of the other three wires are positioned at 90, 100, 
and 110 mm. in the Hg column. Three Gerbrand cumulative 
timers were used to record accumulated time that the Hg 
column exceeded 90 mm. Hg (Channel 1), 100 mm. Hg (Channel 
21, and 110 mm. Hg (Channel 3). The 24 volt D.C. power 
supply provided the current to acti v ate the £our channels 
of the Rustrak recorder. The Rustrak event recorder, 
operating at 15 seconds/inch recorded the level of Hg 
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for the Baumanometer column at 90 mm. (Channel 1), 100 
mm. (Channel 2), and 110 mm. (Channel 3). Channel 4 
was activated by a response key operated by ~•s non-
dominant hand. As~ pumped the Baumanometer bulb, the 
Hg rose in the column and a circuit was completed through 
the barred wire tips at 90, 100, and 110 mm. Hg. 
The S was seated in his wheelchair with dominant 
forearm resting on the apparatus table in a position 
that allowed him to grasp the Bau.manometer bulb. His 
nondominant arm rested extended on a foam rubber cushion 
with index finger in contact with the response key. S 
was given instruction in the Tourniquet Test procedure. 
Circulation to the S's exercising forearm was re-
duced by first extending the arm toward the ceiling and 
then using an elastic Ace bandage to drain the arm of 
venous blood. Immediately before removing the elastic 
Ace bandage, the Vantage sphygmomanometer cuff was 
placed around the ~•supper arm and inflated to a pres-
sure of 250 mm. Hg. The S then lowered his arm to the 
apparatus table and, after a pause of 60 seconds, began 
pumping the bulb to raise the Hg column to 100 mm. and 
maintain it at that level for one minute. (This time 
period was determined and the bleed on the Baumanometer 
bulb adjusted in an attempt to insure that Ss reached 
maximum pain tolerance no more than 180 seconds after 
they finished pumping (as required by the Research and 
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Development Committee of LBVAH). S was instructed to 
press the response key: (a) when he first experienced 
IMP (threshold), and (b) when he experienced the IMP as 
unbearable (maximum tolerance). !l monitored each~ 
during the Tourniquet Test to insure that S maintained 
the Hg column between 90 and 110 mm. for the one-minute 
interval. Channels 1-3 of the Rustrak recorder provided 
time measures for the level of Hg at 90, 100, and 110 
mm. Channel 4 recorded time to threshold, and maximum 
IMP tolerance. The cumulative counters provided an 
accurate measure of the amount of Hg displaced during 
the time period for the Tourniquet Test. The apparatus 
is designed to provide a constant rate of work over time. 
During the Tourniquet Test there exists a rare 
possibility of arterial thrombosis due to extra-arterial 
compression. Extra-vasation of blood from the capil-
laries may occur due to obstruction of venous blood flow 
from the limb. These possibilities were minimized, if 
not completely eliminated, by careful selection of ~s. 
Those with a history of arterial diseases such as hyper-
tension, arteriosclerosis, angina pectoris, myocardial 
infarction, and cerebrovascular episodes were excluded 
from the study. Candidates who were known to have a 
bleeding diathesis or who were on anticoagulants were 
also excluded. 
Each S was examined by a physician for any evidence 
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of arterial or venous disease with particular emphasis 
on the extrajty to be used for the Tourniquet Test. A 
capillary fragility test (Rumpel-Leede test*) was done 
and only those whose results were normal were included 
in the study. 
Ischemic muscle pain (IMP) offers an objective 
measure of pain threshold and tolerance. It is essen-
tial to use an objective measure of pain when comparing 
the effectiveness of different treatment modalities in 
pain management for two reasons. First, it permits 
inter-Subject comparisons for a quantified stimulus (as 
might be used in cross-cultural studies). Second, it 
permits intra-Subject comparisons which are critical 
in evaluating treatment methods. 
Of the available objective pain measures, the 
ischemic measure is superior for a number of reasons: 
(a) IMP is experienced as diffuse, deep, and dull, and 
is more comparable to common clinical pain than that 
produced by electric shock or focused intense heat; (b) 
it is brief and its duration is controlled by the~; 
(c) muscle contraction will involuntarily release well 
*A circle 2.5 cm. in diameter is marked on the skin 
over the anteromedial aspect of the forearm with the upper 
edge of the circle 4 cm. below the flexor crease of the 
elbow. The cuff of a sphygmomanometer is then applied 
around the arm above the circle and half-inflated to a 
pressure midway between systolic and diastolic blood pres-
sure for five minutes. A count of petichiae within the 
circle is made. Less than ten is normal. 
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before the ischemia can become physically harmful; (d) 
its validity is supported by the fact that it responds 
to analgesic medication (Smith, Egbert, Markowitz, 
Mosteller, & Beecher, 1966; Smith, Lowenstein, Hubbard, 
& Beecher, 1968; Smith & Beecher, 1969); and (e) test-
retest reliability for maximum pain tolerance on the 
Submaximum Effort Tourniquet Test has been reported as 
~=.89 (N=38) for one week (Sternbach, Murphy, Timmermans, 
Greenhoot, & Akeson, 1974). 
The Tourniquet Test provided two time measures, 
time to pain threshold and time to maximum pain tolerance 
as measured from the point when the Hg column first 
reached the 90-110 criterion range from which the effect 
of RIA and of placebo medication on experimental pain 
were calculated. 
The Revised Stanford Profile Scales of Hypnotic 
Susceptibility: Form II (SPSHS:II) (Weitzenhoffer & 
Hilgard, 1967). The SPSHS is designed to yield not only 
a measure of general hypnotic susceptibility, but mea-
sures of differential susceptibility to a variety of 
suggestions within the induced hypnotic state. As in 
most measures of hypnotic responsiveness, a brief stan-
dard induction of hypnosis is given followed by increas-
ingly difficult suggestions (tests) to which hypnotized 
persons are known to respond. 
A total score of 27 is possible on both Forms I and 
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II, and a profile reflecting special areas of suscepti-
bility can be constructed using the six subscales pro-
vided. These include: (a) Agnosia and Cognitive Dis-
tortion (AG); (b) Hallucinations-Positive (HP); (c) 
Hallucinations-Negative (HN); (d) Dreams and Regressions 
(DR); (e) Amnesia and Post-hypnotic Compulsions (AM); 
and (f) Loss of Motor Control (MC). Although these sub-
scales group tests on the basis of intended functions 
(face validity), they take into account the results of 
factor analysis (Lauer, 1965) of the original Stanford 
Hypnotic Susceptibility Scale (SHSS), Forms A and B 
(Weitzenhoffer & Hilgard, 1959). 
The standardization sample on which reliability 
estimates are based consists of 155 Stanford University 
undergraduates (70 males and 85 females) who had pre-
viously taken the SHSS, Forms A and 0. The sample is 
not random because of self-selection factors and the 
elimination of Ss who scored 0-3 on Form A (because of 
the frustrations inherent in spending two hours in 
testing when essentially nothing that is suggested 
happens) . 
The Manual reports that there is little practice 
effect, and Forms I and II can be considered equivalent. 
(There is no significant difference in their means.) 
By considering each form as half of a longer 54-point 
test, the split-half reliability coefficient (reflecting 
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internal consistency) stepped up by the Spearman-Brown 
Formula is .88. Test-retest reliability based on the 
product-moment correlation between the total scores of 
Forms I and II is .78. This estimate is actually low 
because it excludes the scores of very poor hypnotic 
~s whose performance is very consistent. Subscale re-
liabilities stepped up by the Spearman-Brown Formula 
range from .66 to .86. Subscale intercorrelations range 
from .38 to .68 indicating the presence of a common 
factor running through the subscales, although they are 
independent enough to be valuable. 
In the present study, hypnotic susceptibility was 
measured by the total score of the SPSHS:II. 
The McGill Pain Questionnaire (Melzack, 1975). The 
McGill Pain Questionnaire was designed to provide quan-
titative measures of clinical pain that can be treated 
statistically. It is unusual in that it focuses not 
only on the intensity dimension of pain perception, but 
on the sensory and affective qualities of the experience. 
The questionnaire was originally constructed by 
asking ~s to classify 102 words, obtained from the clin-
ical literature relating to pain into smaller groups that 
describe different aspects of pain experience. On the 
basis of the data, the words were categorized into three 
major classes and 16 subclasses. The classes are: (a) 
words that describe the sensory qualities of the experience 
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in terms of temporal, spatial, pressure, thermal, and 
other properties; (b) words that describe affective 
qualities in terms of tension, fear, and autonomic pro-
perties that are part of the pain experience; and (c) 
evaluative words that describe the subjective intensity 
of the total pain experience. 
To determine the pain intensities implied by the 
words within each subclass, groups of doctors, patients, 
and students were asked to assign an intensity value to 
each word, using a numerical scale ranging from 1 to 5 
in which each number is associated with the following 
words: 1, mild; 2, discomforting; 3, distressing; 4, 
horrible; 5, excruciating. Although the precise inten-
sity scale values differed for the three groups, all 
three agreed on the positions of the words relative to 
each other. This agreement on the intensity relationships 
among pain descriptors is all the more impressive given 
the different cultural, socio-economic, and educational 
backgrounds of the ~s. 
The questionnaire is comprised of a top sheet to 
record medical information (such as diagnosis and drug 
intake), line drawings of the body to indicate the spatial 
distribution of pain, and a list of pain descriptors di-
vided into subclasses and rank ordered. The Sis instruc-
ted to select those words that describe his present pain, 
omitting any categories that are unsuitable and selecting 
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a single word in each appropriate category. (Category 
and subclass are used synonymously here.) The question-
naire is completed with the aid of an administrator who 
reads the instructions aloud and answers any questions 
that Smay have. Fifteen to twenty minutes are typically 
required for the initial administration. 
The Pain Rating Index based on the patients' mean 
scale values (PRI(S)) is derived from the work of Melzack 
& Torgerson (1971). The assigned values of the words 
chosen by~ are added up to obtain a score for each cate-
gory and a total score for all categories. Because the 
PRI(S) relies primarily on the specification of pain pro-
perties such as burning, wrenching, and shooting, it is 
less subject to the effects of immediate psychological 
factors than most pain measures (Melzack, 1975). 
The PRI(S) of the McGill Pain Questionnaire con-
stituted the measure of chronic pain experience. 
Procedure 
The present investigation was presented to the ~s 
as a study to compare the effectiveness of hypnosis and 
a strong analgesic medication for relief of pain. Medi-
cal, rather than psychological overtones of the research 
were stressed. 
The study consisted of three sessions, each sep-
arated by at least 48 hours: (a) Baseline control, (b) 
Hypnotic analgesia, and (c) Placebo analgesia. Ss were 
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assigned to treatment sequence A, B, C or A, C, B. Three 
Investigators (! 1 , ! 2 , and ! 3 ) collected the data. To 
control for experimenter bias, each I had no knowledge of 
the S's response to prior procedures. Presentation of 
the two treatment sequences was varied so that !i did not 
know which treatment had preceeded her administration of 
the Tourniquet Test. Figure 1 is a flow chart depicting 
the three sessions, including medical procedures, Tourni-
quet Tests, and self-ratings by the~-
Initial evaluation. At the time of scheduling for 
initial evaluation at the SCI Pain Clinic, ~ was instructed 
not to take any medication (prescribed or other) within 
four hours of the evaluation appointment or the three data-
gathering sessions. 
During the evaluation, a physician completed the 
S's cardiovascular history and physical examination. S 
then read and signed the consent form. S was asked to 
rate his present clinical pain on a Pain Estimate scale 
from 0-100, where 0 represents the absence of pain and 
100 represents a degree of pain which would make living 
intolerable (Sternbach, 1974). The McGill Pain Question-
naire and the Stanford Profile Scales of Hypnotic Suscep-
tibility: Form II (SPSHS:II) were then administered by 
!2• Next !i read aloud instructions explaining the Tour-
niquet Test and the sensations to be expected. She sim-
ulated the procedure with S (without actually using the 
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Initial Evaluation 
Physician completes cardiovascular problem interviev 
Physician administers Rumpel-Leede Test 
S reads and signs a:msent fonn 
S rates current clinical pain (0-100) b administers M:Gill Pain Questionnaire 
b administers SPSHS:II 
S sirrn.llates 'Iburniquet Test 
,!1 administers practice 'Iburniquet Test 
,!1 administers 'Ibum.iquet Test 
Session B 
Session A 
S rates current clinical pain (0-100) 
S simulates Tourniquet Test 
b interviev re: past adverse reactions to rreds 
S rates current clinical pain ( 0-100) 
f1 administers Tourniquet Test 
s rates current clinical pain (0-100) 
S sirrn.llates 'Ibumiquet Test 
,!2 irrplerrents RIA 
,!1 delivers :i;::ost-hypnotic cue for analgesia S rates current clinical pain (0-100) 
1._ administers 'Ibumiquet Test 
Session C 
S rates current clinical pain (0-100) 
S reads description of med 
Nurse administers me:l. 
30-35 minute waiting period during which S 
sirrn.llates 'Iburniquet Test -
S completes side effects checklist 
,!1 delivers :i;::ost-hypnotic cue for analgesia S rates current clinical pain (0-100) 
!i administers Tounri.quet Test 
FIG. 1. Procedural fla-v chart. S proceeds from Initial Evaluation 
through Sessions A, B, C or through A, C, B. 
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apparatus). To further insure S's understanding of the 
procedure, a shortened practice trial was administered 
using ~'s nondominant arm without inflating the sphygmo-
manometer cuff. S was asked to signal by pressing a key 
with his opposite hand to simulate: (a) the point that 
he first experienced ischemic pain, and (b) the maximum 
tolerable pain, or the point at which he could no longer 
continue to bear the pain. S was then asked if he was 
willing to continue in the study. If he agreed, the 
Tourniquet Test was administered using his dominant fore-
arm.* 
Session A: baseline pain response. This session 
was designed primarily to gather baseline data for each 
s. S rated his present clinical pain on the Pain Estimate 
(0-100) scale. To refresh his memory of the Tourniquet 
Test procedure, he briefly simulated that procedure (with-
out apparatus). !i then interviewed~ regarding past 
adverse reactions to any prescribed medications. ~ again 
rated his present clinical pain on the Pain Estimate t0-
100) scale, and the Tourniquet Test was administered. 
Session B: hypnotic analgesia. ~ rated his pre-
sent clinical pain on the Pain Estimate (0-1001 , scale. 
To refresh his memory of the Tourniquet Test procedure 
*These data were not included in the data analysis. 
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he briefly simulated that procedure (without apparatus). 
! 2 implemented RIA (see Appendix), awakened~' and before 
leaving, requested that Snot tell !i which treatment he 
had been given. I entered, delivered the post-hypnotic 
-1 
cue for analgesia, and asked S to rate his present clin-
ical pain on the Pain Estimate (0-100) scale. The Tour-
niquet Test was then administered. 
S~ssion C: placebo analgesia. S rated his present 
clinical pain on the Pain Estimate (0-100) scale. I 
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then read aloud to S written information about the phar-
macology of analgesia and the particular "medication" 
being used. Its virtues were extolled to the point of 
indicating its comparability to any other prescribed 
analgesic. At this point the placebo was administered by 
a nurse who had been told that he/she was participating 
in a double blind drug study. (This placebo was an inert 
capsule provided by LBVAH Pharmacy Service especially 
for this study.) S was observed for "side effects" while 
the "medication" took effect, and near the end of this 
waiting period he again simulated the Tourniquet Test 
procedure (without apparatus). Thirty-five minutes after 
administration of the placebo~ was asked to fill out a 
medication side effects checklist and to record any other 
observations he wished to make about his experience. 
Before leaving, ! 3 requested that Snot tell !i which 
treatment he had been given. ! 1 entered and delivered 
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the post-hypnotic cue for analgesia. S again rated his 
present clinical pain on the Pain Estimate (0-100) scale 
and underwent the Tourniquet Test. Before leaving, he 
was assured that any effects of the medication would sub-
side within two hours. 
At the end of the last session, a standard post-
experimental inquiry was conducted to discuss the S's 
performance and perceptions of the study with him. At 
that time, S was given an appointment for debriefing. 
-RESULTS 
The data for analysis to test the hypotheses in-
cluded the following variables: 
(a) the pre-treatment clinical Pain Estimates for 
Sessions Band C; 
(b) the post-treatment clinical Pain Estimates for 
Sessions Band C; 
(c) time to pain threshold on the Tourniquet Test for 
Sessions A, B, and C; 
(d) time to maximum pain tolerance on the Tourniquet 
Test for Sessions A, B, and C; 
(e) the total score for hypnotic susceptibility from 
the SPSHS:II; and 
(f) the PRI(S) score from the McGill Pain Questionnaire. 
The time measures from the Tourniquet Test (c and d) were 
adjusted by square root transformation to approximate a 
more linear distribution for each of these two variables 
(Walker & Lev, 1953). 
General linear hypothesis methodology was used to 
evaluate the hypotheses (Bottenberg & Ward, 1960; Kerlinger 
& Pedhazur, 1973; Ward & Jennings, 1973). This approach 
allowed the use of linear models which were not restricted 
to the linear models used in classical analysis of variance 
(ANOVA) and analysis of covariance (ANCOVA). (It may be 
.._ _ --"·~~- ~""""'!1!!11!1! __________ ______________________________ _ 
-
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noted at this point that classical fixed effects ANOVA 
and ANCOVA are subsets of general linear hypothesis meth-
odology). General linear hypothesis methodology is use-
ful in addressing problems concerned with complex phe-
nomena because it allows flexibility in formulating the 
questions to be answered and then structures the statis-
tical analysis in those terms. 
In this type of methodology, two linear models 
(i.e., regression equations) are compared in terms of the 
reduction of the multiple correlation coefficient squared 
(R2 ). The model with the larger number of predictors is 
referred to as the full model, and the model with the 
smaller number of predictors is called the restricted 
model. The reduction in ~ 2 is~ distributed with degrees 
of freedom df 1/df 2 according to the following equation 








(df) 1 = 
R2 of the full model, 
R2 of the restricted model, 
n - n 
' 
the difference between the 
-f -r 
number of linearly independent predictor 
vectors of the full (~f) and restricted 
(n) models, and 
-r 
(df) 2 = N - ~f' where N is the total number of 
cases. 
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In this investigation each hypothesis was tested by com-
paring an appropriate full model (having the larger 
number of predictors) with a corresponding restricted 
model (.havirig the smaller number of predictors) in terms 
of the reduction of R2 . 
The design of this experiment can be described in 
terms of criterion and predictor variables. There are 
two criterion variables each for Hypotheses 1, 2, and 4: 
a clinical pain variable and an experimental pain vari-
able. Hypothesis 3 has only a clinical pain criterion 
variable. For all four hypotheses the clinical pain 
criterion variable includes two measures: the post-treat-
ment clinical Pain Estimates for Sessions B(RIA) and C 
(placebo). The experimental pain criterion variable also 
includes two measures: time to maximum pain tolerance on 
the Tourniquet Test for Sessions B (.RIA) and C (placebo). 
A separate linear models analysis for clinical pain and 
for experimental pain was necessary to evaluate each of 
Hypotheses 1, 2, and 4. A single linear models analysis 
for clinical pain was necessary to evaluate Hypothesis 3. 
The predictor variables include treatment, covari-
ate, and Subject variables . . The treatment variable can 
be broken down into two levels, RIA and placebo. For 
clinical pain the covariates are pre-treatment clinical 
Pain Estimates for Sessions B (RIAt and C (placebo), the 
total score for hypnotic susceptibility from the SPSHS:II, 
and the PRI(.S) score from the McGill Pain Questionnaire. 
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For experimental pain the covariates are time to threshold 
for Sessions A (baseline), B (RIA), and C (placebo); time 
to maximum pain tolerance for Session A (baseline); the 
total score for hypnotic susceptibility from the SPSHS:II; 
and the PRI(S) score from the McGill Pain Questionnaire. 
Rather than using pre-post difference scores, the effect 
of treatments was analyzed by using linear models which 
tested for post-treatment effects on the criterion mea-
sures, while controlling for the effects of the pre-
treatment covariates (Jennings, 1971). 
Since a repeated measures design was used in which 
the same Ss received both levels of treatment, it was nec-
essary to include a binary predictor variable for each S 
in each regression equation to control for the effect of 
Ss (Ward, personal communication, 1977). Incidentally, 
this procedure also provided a statistical control for 
possible order effects (in that a predictor for order is 
redundant i.e., a linear combination of a subset of the 
Subject variables). A non-interaction model between Ss 
and other predictors was assumed in the analyses. 
For clinical pain the starting full model including 
all variables necessary to test Hypotheses 4 and 2 is 
stated as follows: 
Model lCJO: Post= a 1BPRE + a 2PRI(S) + a 3SPSHS + E 
where Post*= a vector of the post-treatment clinical 
*Note that "Post" and "Tol" are criterion variables. 
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Pain Estimates for Session B (RIA); 
BPRE = a vector of the pre-treatment clinical 
Pain Estimates for Session B (RIA); 
PRI(S) = a vector of the PRI(S) scores from the 
McGill Pain Questionnaire; 
SPSHS = a vector of the total scores for hypnotic 
susceptibility from the SPSHS:II; 
E = a vector of error terms for Model lc 30 ; 
a . = least squares regression coefficients 
J 
(j = 1-3). 
For experimental pain the starting full model in-
cluding all variables necessary to test Hypotheses 4 and 
2 is stated as follows: 
Model 1~ 30 : Tol = a 1Athres + a 2Atol + a 3Thres + a 4PRI(S) 
+ a5SPSHS + E 
where Tol* = a vector of time to maximum pain tolerance 
for each s for Session B (RIA) ; 
Athres = a vector of time to pain threshold for each 
s for Session A (baseline) ; 
Atol = a vector of time to maximum pain tolerance 
for each s for Session A (baseline) ; 
Thres = a vector of time to pain threshold for each 
s for Session B ( RIA) ; 
PRI(S) = a vector of the PRI(S) scores from the 
*Note that "Post" and "Tol" are criterion variables. 
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McGill Pain Questionnaire; 
SPSHS = a vector of the total scores for hypnotic 
susceptibility from the SPSHS:II; 
E = a vector of error terms for Model 1E30 ; 
a . = least squares regression coefficients 
J 
( j = 1 to 5) . 
For clinical pain the starting full model including 
all variables necessary to test Hypotheses 3 and 1 is 
stated as follows: 
Model lCGO Post= a 1Txl + a 2Tx2 + a 3BPRE 
+ a 5PRI(S) + a 6SPSHS + 
+ a 4CPRE 
s.s(i) + E 
l 
where Post*= a vector of the post-treatment clinical 
Pain Estimates for both Sessions B (RIA) 
and C (placebo) ; 
Txl = a vector of treatment level for Session B 
( RIA) ; 
Tx2 = a vector of treatment level for Session C 
(placebo) ; 
BPRE = a vector of the pre-treatment clinical 
Pain Estimates for Session B (RIA); 
CPRE = a vector of the pre-treatment clinical 
Pain Estimates for Session C (placebo); 
PRI(S) = a vector of the PRI(S) scores from the 
McGill Pain Questionnaire; 
*Note that "Post 11 and "Tol" are criterion variables. 
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SPSHS = a vector of the total scores for hypnotic 
susceptibility from the SPSHS:II; 
5 Ci) = binary vectors of 1 for the ith S, 0 
otherwise (i = 1 to 3 0) ; 
E = a vector of error terms for Model 1C60 ; 
a. = least squares regression coefficients 
J 
( j = 1 to 6) ; 
s. = least squares regression coefficients 
)_ 
(i = 1 to 30); 
For experimental pain the starting full model in-
cluding all variables necessary to test Hypotheses 3 and 
1 is stated as follows: 
Model 1E 60 : Tol = a 1Txl + a 2Tx2 + a 3Athres + a 4Atol 
+ a5Thres + a 6PRI(S) + a 7SPSHS 
where 
+ s,s(i) + E )_ 
Tol* = a vector of time to maximum pain tolerance 
for each S for both Sessions B (RIA) and 
C ( p 1 a C eb O) ; 
Txl = a vector of treatment level for Session B 
(RIA); 
Tx2 = a vector of treatment level for Session C 
(placebo); 
Athres = a vector of time to pain threshold for each 
S for Session A (baseline); 
*Note that "Post" and "Tol" are criterion variables. 
34 
Atol = a vector ot time to maximum pain tolerance 
for each S for Session A (baseline); 
Thres = a vector of time to pain threshold for 
each S for both Sessions B (RIA) and C 
(placebo); 
PRI(S) = a vector of the PRI(S) scores from the 
McGill Pain Questionnaire; 
SPSHS = a vector of the total scores for hypnotic 
susceptibility from the SPSHS:II; 
S(i) = binary vectors of 1 for the ith ~' 0 
otherwise (i = 1 to 30); 
E = a vector of error terms for Model lEEO; 
a = least squares regression coefficients j 
(j = 1 to 7); 
s. = least squares regression coefficients 
l 
(i = 1 to 30). 
The hypotheses were tested by successive comparisons 
of the full model · (having the greater number of predictors) 
with the restricted model (having the smaller number of 
predictors). The resulting F-ratios provided tests of the 
reduction of the squared multiple correlation coefficients 
(R2s). Tables 1 and 2 summarize the results of testing 
Hypotheses 4 and 2 for clinical and experimental pain, re-
spectively. Tables 3 and 4 summarize the results of test-
ing Hypotheses 3 and 1 for clinical and experimental pain, 
respectively. The four tables show the variables excluded 
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or combined, the number of predictors, the degrees of 
2 freedom, and the values of R for each model; the models 
compared; and the value of F for each comparison. (Note 
that Tables 1 and 2 are based on only one treatment ses-
sion i.e., RIA, while Tables 3 and 4 are based on both 
RIA and placebo sessions.) 
Table 1 
Comparison of Full and Restricted M::>dels for Clinical Pain 
for Hyp:,theses 4 and 2 






















Comparison of Full and Restricted M::>dels for Experimental Pain 
for Hypotheses 4 and 2 
R2 
Mxl.els 
M::>del Variables Nurrber of df Compared F 
Excluded Predictors 1 Full-
Restricted 
1E30 None 6 .7616 
2 PRI(Sl 5 1/24 .7466 
~o - 2 4.16 
3 SPSHS 5 1/24 .7204 1E30 - 3 1.58 
1An additional predictor (i.e., the unit vector) was 
included in the starting full model and successive models 
a result of using the Statistical Package for the Social 
Sciences (SPSS) _ to solve the regression equations. 
36 
Table 3 
Comparison of Full and Restricted .tvbdels for Clinical Pain 
for HYIX)theses 3 and 1 
M:xiels 
.tvbdel Variables Excluded Nurrber of df R2 Compared F 
or Corrbined Preclictorsl - Full-
Restricted 
1
c60 None 32 .9619 
2 Exclude SPSHS 31 1/28 .9524 1C60- 2 6.78* 
3 Exclude PRI(S) 31 1/28 .9575 1c60- J 3.14 
4 Corrbine BPRE & CPRE 30 1/29 .9538 3 - 4 2.46 
5 Corrbine Txl & Tx2 29 1/30 .9486 4 - 5 3.46 
*~. 05. 
Table 4 
Comparison of Full and Restricted M:xiels for Experimental Pain 












Number of df R2 
Predictors 2 
32 .9845 
31 1/28 .9839 
30 1/29 .9839 






2 - 3 





1Because linear dependencies are contained in the set 
of predictors for Model 1 , the actual full model in the 
statistical analysis cont~fRs only 32 linearly independent 
predictors. 
2Because linear dependencies are contained in the 
set of predictors in Model 1E 60 , the actual full model in the statistical analysis contains only 32 linearly indepen-
dent predictors. 
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Tables 5 and 6 show the means, standard deviations, 
and intercorrelations of the variables defined in the 
starting full model and combinations of these variables 
used in later linear models (without square root transfor-
mations). 
Table 5 
Means and Standard Deviations of Variables 
Variable Mean S.D. 
SPSHS 8.83 7.83 
PRI (S) 25.94 12.69 
Athres 34.50 39.85 
Bthres 1 36.60 40.45 
Cthresl 39.26 40.90 
Thres 37. 93 40.37 
Atol 102.77 73.40 
Btol2 112.43 78.58 
Ctol 2 114.37 82.47 
Tol 113.40 79.87 
BPRE 44.90 30.55 
CPRE 43.70 29.83 
Pre 44.30 28.72 
Bpost 3 35.53 28.97 
Cpost 3 38.10 26.97 
Post 36.82 27.39 
1Bthres and Cthres represent time to pain threshold 
on the Tourniquet Test for Sessions B (RIA) and C (placebo), 
respectively. 
2Btol and Ctol represent time to maximum pain toler-
ance on the Tourniquet Test for Sessions B (RIA) and C 
(placebo), respectively. 
3Bpost and Cpost represent post-treatment Pain Esti-
mates for Sessions B (RIA) and C (placebo), respectively. 
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Table 6 
Intercorrelations of Variables 
Variable 
Variable SPSHS PRI Athres Atol Thres Tol BPRE CPRE PRE FOST 
SPSHS .17 -.11 .13 -.11 .18 .07 .12 .21 .05 
PRI -.05 .12 -.03 -.08 .26 .30 .58 .47 
Athres .42 .95 .40 -.06 -.08 -.15 -.20 
Atol .41 .81 .02 -.02 .00 -.01 
Thres .43 -.09 -.07 -.17 -.20 
Tol -.02 -.09 -.12 -.13 
BPRE -.55 .49 .42 
CPRE .46 .44 
Pre .90 
Post 
The hypotheses were tested in the order 4, 2, 3, and 
1. Hypotheses 4 and 2 were tested first to determine whe-
ther chronic pain experience (as measured by the PRI(S) 
score from the McGill Pain Questionnaire) and hypnotic sus-
ceptibility (as measured by the total score from the ; 
SPSHS:II) should be included as covariates in the analyses 
to test Hypotheses 3 and 1. Hypothesis 3 which tests for 
interaction was then evaluated before Hypothesis 1 which 
tests for main effects. 
Hypothesis 4 states that the effect of RIA on (a) 
clinical pain and (b) experimental pain is significantly 
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related to chronic pain experience when the effect of 
hypnotic susceptibility is controlled. To evaluate this 
hypothesis a full model, which included the PRI(S) score 
from the McGill Pain Questionnaire was compared with a 
restricted model, which excluded the PRI(S) score, using 
an F test. For clinical pain the~ ratio was not sig-
nificant, ~ (1, 26) = 0.32, p > .05; for experimental pain 
the F ratio was not significant, ~ (1, 24) = 4.16, p>.05. 
The hypothesis is therefore rejected. 
Hypothesis 2 states that the effect of RIA on (a) 
clinical pain and (b) experimental pain is not signifi-
cantly related to hypnotic susceptibility when the ef-
fect of chronic pain experience is controlled. To 
evaluate this hypothesis a full model, which included 
the total score for hypnotic susceptibility from the 
SPSHS:II was compared with a restricted model, which ex-
cluded the score for hypnotic susceptibility, using an 
F test. For clinical pain, the~ ratio was not signifi-
cant, F (1, 27) = 0.71, p>:os, and for experimental pain 
the F ratio was not significant,~ (1, 24) = 1.58, p>.05. 
The hypothesis is therefore supported. 
Hypothesis 3 states that differences between the 
effect of RIA and the effect of an oral placebo on clin-
ical pain are not constant for different levels of pre-
treatment clinical Pain Estimates when the effects of 
hypnotic susceptibility and chronic pain experience are 
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controlled. To evaluate this hypothesis a full model 
which included separate predictors for Session B (RIA) 
and Session C (placebo) pre-treatment clinical Pain Esti-
mates, was compared with a restricted model which com-
bined the pre-treatment clinical Pain Estimates into one 
predictor for the two sessions. This ocmparison provided 
a test for interaction (i.e., nonhomogeneous slopes). 
The r ratio was not significant, r (1, 29) = 2.46, E>.05, 
and the hypothesis of nonhomogeneous slopes is rejected.* 
Hypothesis 1 states that RIA is significantly more 
effective than an oral placebo in (a) reducing clinical 
pain, and (b) increasing experimental pain tolerance 
when the effects of hypnotic susceptibility and chronic 
pain experience are controlled. To evaluate this hypo-
thesis a full model which included separate predictors 
for Session B (RIA) and Session C (placebo) treatment ef-
fects was compared with a restricted model which combined 
treatment effects for the two sessions into one predictor 
(i.e., the unit vector) For clinical pain the F ratio 
was not significant, F (1, 30) = 3.46. E>.05. Similarly, 
for experimental pain the r ratio was not significant, 
r (1, 30) = 1.80, E5.05. The hypothesis is therefore re-
jected, i.e., there is no difference in treatment effects. 
*Note that Hypothesis 3 applies only to clinical pain. 
DISCUSSION 
Interpreting the results of the present study in-
volves examining the interrelationships between individual 
characteristics of the~' i.e., his chronic pain exper-
ience, pre-treatment level of clinical pain, and hypnotic 
susceptibility; and the treatment effects. 
The results of this study support one of the two 
hypotheses derived from Joseph Barber's results in applying 
RIA to dental pain (Hypotheses 1 and 2). In review, Joseph 
Barber found RIA to be effective in the control of sub-
threshold electrical tooth stimulation regardless of S's 
hypnotic susceptibility. He also found RIA to be effective 
in the control of acute clinical dental pain (although hyp-
notic susceptibility was not measured in these Ss). 
In the present study RIA was not significantly more 
effective than an oral placebo in (a) reducing clinical 
pain and (b) increasing experimental pain tolerance (when 
hypnotic susceptibility was controlled). These results 
indicate that for clinical and experimental pain, the ini-
tial effectiveness of RIA or placebo is comparable. Al-
though this result initially seems in conflict with J. 
Barber's work, Barber in fact never compared the effect 
of RIA with a control group. He demonstrated the ef£ect 
of RIA for experimental pain by measuring pain threshold 
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electrical tooth stimulation before implementing RIA, after 
delivering the post-hypnotic cue for analgesia, and after 
returning ~s to their normal level of awareness. 
Additionally, in the present study, the effect of RIA 
on clinical and experimental pain was not significantly 
related to hypnotic susceptibility (when the effect of 
chronic pain experience is controlled). These results 
support J. Barber's premise that the effectiveness of RIA 
(an indirect hypnotic approach) is not related to hypnotic 
susceptibtility. Nevertheless, they do not corroborate 
his findings that for all ~s RIA successfully raised the 
pain threshold for electrical tooth stimulation to an ar-
bitrarily defined limit regardless of hypnotic suscepti-
bility. 
Interestingly, when the effects of RIA and placebo 
are combined into a single treatment variable, the effect 
of treatment on clinical pain is related to hypnotic sus-
ceptibility. (See Table 3.) This implies that the effect 
of placebo treatment is significantly related to hypnotic 
susceptibility, a finding which represents another depar-
ture from the literature. 
The results of the present study do not support 
Hypotheses 3 and 4. Both of these hypotheses are concerned 
with the relationship between the effect of treatment and 
either chronic pain experience or pre-treatment level of 
clinical pain. The results of testing Hypothesis 4 
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indicate that the effect of RIA on clinical pain and ex-
perimental pain is not significantly related to chronic 
pain experience (when the effect of hypnotic susceptibil-
ity is controlled). Therefore, the PRI(S), which measured 
chronic pain experience, did not contribute significantly 
to the variance and it was not included as a covariate in 
the subsequent analyses. It may be noted, however, that 
the PRI(S) and the pre-treatment clinical Pain Estimate 
are significantly correlated,~ (28) = .58, E<.01. The 
pre-treatment clinical Pain Estimate was included as a 
covariate in all subsequent analyses to determine the ef-
fect of treatment on clinical pain. 
The results of testing Hypothesis 3 indicate that 
for clinical pain there is no interaction between the ef-
fect of RIA, the effect of an oral placebo, and different 
levels of pre-treatment clinical Pain Estimate (when the 
effect of hypnotic susceptibility is controlled). Thus, 
there are no significant relationships between the effect 
of treatment (RIA or placebo) and either chronic pain ex-
perience or pre-treatment level of clinical pain. 
The use of SCI male veterans who suffer from chronic 
pain syndrome may have contributed to the lack of a sig-
nificant difference in treatment effect for RIA vs. placebo 
in the present study (when the effect of hypnotic suscep-
tibility was controlled). For example, one would expect 
to find the effects of treatment attenuated when dealing 
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with individuals who may be financially compensated £or 
their pain, who frequently have disrupted family lives, 
and who often function in a social milieu in which alcohol/ 
drug abuse is encouraged. 
One of the primary contributions of the present 
study is support for the position that results obtained 
from studies using acute pain or experimental pain (in 
the absence of clinical pain) cannot be generalized to 
the control of chronic pain. It may be unrealistic to 
expect a single exposure of any technique to have signi-
ficant impact on pain in an individual whose lifestyle 
has been altered to accommodate chronic pain. This pop-
ulation difference may explain the differences between 
our findings and those of J. Barber, who used acute or 
brief experimental dental pain in healthy ~s. 
A number of frequently-cited studies in the liter-
ature on the control of pain were done with samples of 
individuals who had acute pain or who were subjected to 
short-term experimental pain in the absence of clinical 
pain (Bonica, 1974; Melzack, 1973; Sternbach, 1974; Wei-
senberg, 1977). Discrepancies between the results of the 
present study and those studies reflect legitimate dif-
ferences in the effective control of chronic benign pain 
vs. experimental pain, acute pain, and other pain syn-
dromes. Beecher (1959, 1963, 1972) has argued that it is 
not possible to equate laboratory pain with clinical pain 
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produced by pathological processes because the former is 
not accompanied by the anxiety associated with the disease 
process and the threat of disfigurement or death. Simi-
larly, those who treat patients who have chronic benign 
pain contend that it is not possible to equate acute clin-
ical pain with chronic pain because acute pain is not 
accompanied by the emotional components of long-term de-
pression and anxiety (Fordyce, 1976; Sternbach, 1974). It 
is essential that the nature of the pain under investiga-
tion be recognized before generalizing from the results of 
studies in the control of pain. The results presented 
here are applicable specifically to chronic benign pain of 
somatogenic origin. 
With regard to generalizability, practioners/ 
researchers who are interested in applying the results of 
pain control studies to individual chronic pain patients 
must be aware of how the data were obtained, the type of 
pain stimuli used, the conditions of testing, the inde-
pendent measures used, how the data were analyzed, and 
-
the validity of the conclusions drawn. 
It has frequently been noted that placebo and hyp-
notic analgesia seem to involve the elements of suggestion, 
expectations of successful outcome, and anxiety relief 
(T. X. Barber, 1969; Chaves & T. X. Barber, 1974). Chaves 
and T. X. Barber assert that many of the positive claims 
for hypnosis are based on a readiness by the individual to 
accept suggestions, rather than an actual hypnotic effect. 
46 
They conclude that effective pain control depends on a pos-
itive doctor-patient relationship, rather than on hypnotic 
effectiveness. To speculate further, the chronic pain 
patient, compared to a nondisabled individual, has a 
vastly more complex and often negative learning history 
with regard to "people-helping" professionals, and there-
fore may be unable to respond to a brief supportive contact. 
The results of the present study are consistent with T. X. 
Barber's theoretical orientation if one accepts the pre-
mise that one or two exposures are not sufficient to 
develop a positive doctor-patient relationship when the 
patient suffers from a chronic pain syndrome. 
The present study indicates that: (a) RIA is not 
as widely applicable as J. Barber implied; (b) the effec-
tiveness of RIA is not related to the individual's hyp-
notic susceptibility; and (c) the effectiveness of RIA is 
not related to the severity of the individual's chronic 
pain experience. 
It is this author's belief that the impact of any 
one-session treatment is of limited value when evaluating 
the potential for effectively managing an individual's 
chronic pain. There is a paucity of other research com-
paring the effectiveness of different pain management 
procedures using chronic benign pain patients. Additional 
studies which involve multiple exposures to treatment over 
time are needed. Such studies are necessary to verify 
predictors of effective long-term pain management, and to 
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compare the efficacy over time of different management 
procedures. 
Further research to investigate and clarify the 
applicability of RIA for pain reduction in other chronic 
pain samples is desirable, since the effectiveness of the 
RIA technique has to date only been studied using acute/ 
experimental dental pain and chronic benign pain (this 
study). 
It would be interesting to evaluate the effectiveness 
of RIA in reducing clinical pain using repeated exposures 
to that technique. A comparison of hypnotic analgesia pro-
duced in response to direct suggestions vs. indirect sug-
gestions (as in RIA) would also be of value. 
Furthermore, investigation of practitioner variables 
(including patient ratings of practitioners) which enhance 
or detract from the successful application of RIA (or other 
hypnotic approaches) deserves more study, especially in 
view of the position taken by Chaves and T. X. Barber. In 
the current study RIA was implemented by a licensed clin-
ical psychologist who has used hypnosis extensively in 
the management of chronic pain for the last seven years. 
Nevertheless, Joseph Barber might have obtained different 
results as a function of differences in style. In short, 
the RIA technique, while new, clearly deserves further 
research, as do other indirect hypnotic approaches. 
The statistical control of the effect of pre-
treatment clinical pain ratings utilized here is recom-
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mended in further research with pain patients since this 
covariate, as in this study, is likely to account for a 
sizeable proportion of the variance. The measurement of 
hypnotic susceptibility is a necessity in studies involving 
hypnosis and may be desirable in studies involving self-
regulatory procedures, e.g., biofeedback, relaxation, etc. 
The need for experimental pain measures in the study 
of chronic clinical pain is questiona6le. The use of ex-
perimental pain is essential only in those studies which 
do not use pain patients; generalizing the results of such 
studies to real pain patients is usually inappropriate. 
In research using pain patients, experimental pain measures 
do not contribute useful information. In the final anal-
ysis, chronic pain patients' beliefs about the effective-
ness of treatment. and an increased ability to participate 
in more productive lifestyles are the sine qua non of 
effective pain management. 
CONCLUSION 
The major purpose of the present study was to see if 
RIA is as widely applicable as J. Barber implied. In fact, 
it is not, but J. Barber was correct in asserting that the 
effectiveness of RIA is unrelated to hypnotic susceptibil-
ity. Furthermore, the severity of chronic pain experience 
that an individual brings to the treatment situation does 
not necessarily influence the effectiveness of RIA in con-
trolling his pain. 
At present, the use of hypnosis for the control of 
clinical pain is limi t .ed, because of the widely accepted 
view that hypnotic analgesia can be effective only in a 
minority of patients (J. Barber, 1976). Hypnosis is 
therefore used by many practitioners who work in the 
field of chronic pain only as a last resort. Our findings, 
however, suggest that hypnotic susceptibility may not be 
a predictor of effective pain control when an indirect 
approach (such as RIA) is used. The regular incorporation 
of indirect hypnotic approaches into ch~onic pain manage-
ment programs is appropriate, and practitioners need not 
refrain from offering hypnosis as a means of pain control 
on the basis of low hypnoti6 susceptibility. 
In retrospect, it may have been optimistic to expect 
substantial pain relief from a single RIA session in our 
50 
chronic pain patients. Although the severity of chronic 
pain experience was not related to the effect of RIA in 
this study, the analysis was handicapped by the lack of 
significant pain relief resulting from the single RIA 
session. The severity of pain experience that the indi-
vidual brings to the treatment situation remains a poten-
tially important variable. Further investigation to 
clarify the role of existing pain on response to pain 
management procedures is needed. 
As noted elsewhere, the RIA technique, while new 
and unexplored, seems to bear considerable promise for 
the relief of pain. A major contribution of this work 
appears to be that chronic and acute pain must be dealt 
with as different entities by pain researchers dealing 
with RIA. This specific result buttresses the general 
position held by those who work with chronic pain pa-
tients that the distinction between chronic and acute 
pain states is important (Fordyce, 1976; Sternbach, 1974). 
Further research is necessary to specify and clarify the 
parameters of successful clinical pain reduction through 
RIA, so that the technique can be further developed and 
optimally applied. 
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APPENDIX 
Rapid Induction Analgesia Procedure 
The purpose of the following procedure is to devel-
op complete analgesia and muscular relaxation in as short 
a ti.me as possible (approxi.rna tely 10 minutes) . 
I'd like to talk with you for a moment to see if 
you'd like to feel more comfortable and relaxed than you 
might expect. Would you like to feel more comfortable than 
you do right now? 
I'm quite sure that it will seem to you that I have 
really done nothing, that nothing has happened at all. You 
may feel a bit more relaxed, in a moment, but I doubt that 
you'll notice any other changes. I'd like you to notice, 
though, if you're surprised by anything else you might 
notice. OK, then the really best way to begin feel-
ing more comfortable is to just begin by sitting as com-
fortably as you can right now ... go ahead and adjust 
yourself to the most comfortable position you like 
that's fine. Now, I'd like you to notice how much more 
comfortable you can feel by just taking one very big, 
satisfying deep breath. Go ahead ... big, deep, satis-
fying breath ... That's fine. You may already notice 
how good that feels ... how warm your neck and shoulders 
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can feel ... Now, then. I'd like you to take four 
more very deep, very com£ortable breaths ... and, as you 
exhale, notice . just notice how comfortable your 
shoulders can become . and notice how comfortable your 
eyes can feel when they close ... and when they close, 
just let them stay closed ... that's right, just notice 
that ... and notice, too, how, when you exhale, you can 
just feel that relaxation beginning to sink in ... Good, 
that's fine ... now, as you continue breathing, com-
fortably and deeply and rhythmically, all I'd like you to 
do is to picture in your mind . just imagine a stair-
case, any kind you like. with 20 steps, and you at 
the top ... Now, you don't need to see all 20 steps at 
once, you can see any or all of the staircase, any way you 
like . that's fine ... Just notice yourself, at the 
top of the staircase, and the step you're on, and any 
others you like. however you s.ee it is fine .. 
Now, in a moment, but not yet, I'm going to begin to count, 
out loud, from one to 20, and . as you may already 
have guessed ... as I count each number I'd like you to 
take a step down that staircase ... see yourself step-
ping down, feel yourself stepping down, one step for each 
number I count ... and all you need to do is notice, 
just notice, how much more co.rn£0.rtable and relaxed you can 
feel at each step, as you go down the staircase ... one 
step for each number that I count . the larger the 
number, the farther down the staircase ... the farther 
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down the staircase, the more comfortable you can feel . 
one step for each number .. all right, you can begin to 
get ready . now, I'm going to begin ... one ... one 
step down the staircase ... two . two steps down the 
staircase ... that's fine ..• THREE . three steps 
down the staircase ... and maybe you already notice how 
much more relaxed you can feel ... I wonder if there are 
places in your body that feel more relaxed than others 
. perhaps your shoulders feel more relaxed than your neck 
... perhaps your legs feel more relaxed than your arms 
. I don't know, and it really doesn't matter ... all 
that matters is that you feel comfortable . that's all 
. FOUR •.. four steps down the staircase, perhaps 
feeling already places in your body beginning to relax .. 
. I wonder if the deep relaxing, restful heaviness in your 
forehead is already beginning to spread and flow ... down, 
across your eyes, down across your face, into your mouth 
and jaw ... down through your neck, deep, restful, heavy 
. FIVE . five steps down the staircase ... a 
quarter of the way down, and already beginning perhaps, to 
really enjoy your relaxation and comfort . SIX. 
six steps down the staircase ... perhaps beginning to 
notice that the sounds which were distracting become less 
so ... that all the sounds you can hear become a part of 
your experience of comfort and relaxation ... anything 
you can notice becomes a part of your experience of com-
fort and relaxation ... SEVEN ... seven steps down the 
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staircase ... that's fine. perhaps noticing the 
heavy, restful, comfortably relaxing feeling spreading down 
into your shoulders, into your arms . . . I wonder if you 
notice one arm feeling heavier than the other ... perhaps 
your left arm feels a bit heavier than your right. 
perhaps your right arm feels heavier than your left. 
I don't know, perhaps they both feel equally, comfortably 
heavy ... It really doesn't matter ... just letting 
yourself become more and more aware of that comfortable 
heaviness . or is it a feeling of lightness? I really 
don't know, and it really doesn't matter ... EIGHT ... 
eight steps down the staircase ... perhaps noticing that, 
even as you relax, your heart seems to beat much faster and 
harder than you might expect, perhaps noticing the tingling 
in your fingers . perhaps wondering about the flutter-
ing of your heavy eyelids ... NINE ... nine steps down 
the staircase, breathing comfortably, slowly, and deeply 
. restful, noticing that heaviness really beginning to 
sink in, as you continue to notice the pleasant, restful, 
comfortable relaxation just spread through your body ... 
TEN ... ten steps down the staircase ... halfway to the 
bottom of the staircase, wondering perhaps what might be 
happening, perhaps wondering if anything at all is hap-
pening ... and yet, knowing that it really doesntt 
matter, feeling so pleasantly restful, just continuing to 
notice the growing, spreading, comfortable relaxation 
. ELEVEN ... eleven steps down the staircase. 
59 
noticing maybe that as you feel increasingly heavy, more 
and more com£ortable, there's nothing to bother you, no-
thing to disturb you, as you become deeper and deeper re-
laxed ... TWELVE ... twelve steps down the staircase 
I wonder if you notice how easily you can hear the 
sound of my voice 
words I say ... 
. how easily you can understand the 
with nothing to bother, nothing to dis-
turb ... THIRTEEN ... thirteen steps down the stair-
case, feeling more and more the real enjoyment of this 
relaxation and comfort ... FOURTEEN ... fourteen steps · 
down the staircase . noticing perhaps the sinking, 
restful pleasantness as your body seems to just sink down, 
deeper and deeper into the chair, with nothing to bother, 
nothing to disturb ... as though the chair hoids you, 
comfortably and warmly ... FIFTEEN. fifteen steps 
down the staircase ... three-quarters of the way down 
the staircase ... deeper and deeper relaxed, absolutely 
nothing at all to do ... but just enjoy yourself. 
SIXTEEN ... sixteen steps . down the staircase ... won-
dering perhaps what to experience at the bottom of the 
staircase ... and yet knowing how much more ready you 
already feel to become deeper and deeper relaxed . 
more and more comfortable, with nothing to bother, nothing 
to disturb ... SEVENTEEN ... seventeen steps down the 
staircase ... closer and closer to the bottom, perhaps 
feeling your heart beating harder and harder, perhaps 
feeling the heaviness in your arms and legs become even 
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more clearly comfortable ... knowing that nothing really 
matters except your enjoyment of your experience of com-
fortable relaxation, with nothing to bother, nothing to 
disturb ... EIGHTEEN ... eighteen steps down the stair-
case ... almost to the bottom, with nothing to bother, 
nothing to disturb, as you continue to go deeper and deeper 
relaxed. heavy . comfortable ... restful . 
relaxed. nothing really to do, no one to please, no 
one to satisfy ... just to notice how very comfortable 
and heavy you can feel, and continue to feel as you con-
tinue to breathe, slowly, and comfortably ... restfully 
. NINETEEN ... nineteen steps down the staircase 
... almost to the bottom of the staircase . nothing 
to bother, nothing to disturb you as you continue to feel 
more and more comfortable, more and more rel~xed, more and 
more rested ... more and more comfortable. just 
noticing ... and now ... TWENTY ... bottom of the 
staircase ... deeply, deeply relaxed ... deeper with 
every breath you take. as I talk to you for a moment 
about something you already know a lot about . remero-
bering and forgetting . you know a lot about it, be-
cause we all do a lot of it .. . every moment, of every 
day you remember . and then you forget, so you can re-
member something else ... you can't remember everything, 
all at once, so you let some memories move quietly back in 
your mind ... I wonder, for instance, if you remember 
what you had for lunch yesterday ... I would guess that, 
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with not too much effort, you can remember what you had for 
lunch yesterday ... and yet ... I wonder if you remem-
ber what you had for lunch a month ago today ... I would 
guess the effort is really too great to dig up that memory, 
though of course it is there . somewhere, deep in the 
back of your mind ... no need to remember, so you don't 
... and I wonder if you'll be pleased to notice that the 
things we talk about today, with your eyes closed, are 
things which you'll remember tomorrow, or the next day 
. or next week ..• I wonder if you'll decide to let 
the memory of these things rest quietly in the back of your 
mind ... or if you'll remember gradually, a bit at a time 
... or perhaps all at once, to be again resting in the 
back of your mind ... perhaps you'll be surprised to 
notice that this room is the place for memory to surface 
... perhaps not ... perhaps you'll notice that it is 
more comfortable to remember on another day altogether 
. it really doesn't matter . doesn't matter at all 
. whatever you do, however you choose to remember 
. is just fine . absolutely natural ... doesn't mat-
ter at all ... whether you remember tomorrow or the next 
day, whether you remember all at once, or gradually ... 
completely or only partially ... whether you let the 
memory rest quietly and comfortably in the back of your 
mind ... really doesn't matter at all ... and, too, 
I wonder if you'll notice that you'll feel surprised that 
your visit here today is so much more pleasant and com-
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fortable than you might have expected ... I wonder if 
you'll notice that surprise ... that there are no other 
feelings ... perhaps you'll feel curious about that sur-
prise ... surprise, curiosity . I wonder if you'll 
be pleased to notice that today ... and any day ... 
whenever you notice that you are sitting in this room like 
this ... when you feel your back resting against your 
chair like this . you'll feel reminded of how very com-
fortable you are feeling right now ... even more com-
fortable than you feel even now ... comfortable, relaxed 
... nothing to bother, nothing to disturb . I wonder 
if you'll be reminded of this comfort, too, and deep re-
laxation, by just noticing the column of mercury in front 
of you . perhaps this comfort and relaxation will come 
flooding back, quickly and automatically, whenever you find 
yourself sitting in front of this table ... I don't know 
exactly how it will seem ... I only know, as perhaps you 
also know ... that your experience will seem surpris-
ingly~ pleasant, surprisingly more comfortable, sur-
prisingly more restful than you might expect ... with no-
thing to bother, nothing to disturb ... whatever you are 
able to notice ... everything can be a part of your ex-
perience of comfortableness, restfulness and restfulness 
and relaxation ... everything you notice can be~ part 
of being absolutely comfortable . and I want to remind 
you that whenever Dr. Snow touches your right shoulder, 
like this ... whenever it is appropriate, and only when 
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it is appropriate ... whenever Dr. Snow touches your 
right shoulder, like this ... or whenever I touch your 
right shoulder, like this ... you'll experience a feel-
ing ... a £eeling of being ready to do something ... 
whenever I touch your right shoulder, like this ..• or 
whenever Dr. Snow touches your right shoulder, like this 
... you'll experience a feeling ... a feeling of being 
ready to do something ... perhaps a feeling of being 
ready to be relaxed ... perhaps a feeling of being ready 
to be even more com£ortable ... perhaps ready to know 
even more clearly that there's nothing to bother, nothing 
to disturb ... perhaps ready to become heavy and tired 
... I don't know. but whenever Dr. Snow touches 
your right shoulder, like this ... you'll experience a 
feeling ... a feeling of being ready to do something 
. it really doesn't matter ... perhaps just a feel-
ing of being ready to be even more surprised ... it 
doesn't really matter . nothing really matters but your 
experience 0£ com£ort and relaxation ... absolutely deep 
com£ort and relaxation ... with nothing to bother and 
nothing to disturb ... that's fine ... and now, as you 
continue to enjoy your comfortable relaxation, I'd like 
you to notice how very nice it feels to be this way .... 
to really enjoy your own experience, to really enjoy the 
feelings your body can give you ... and in a moment, but 
not yet . not until you're ready ... but in a moment 
I'm going to count from one to 20 ... and as you know, 
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I'd like you to feel yourself going back up the steps . 
one step for each m.unber . . . you' 11 have all the time 
you need . after all, time is relative . feel your-
self slowly and comfortably going back up the steps, one 
step for each number I count .•. more alert as you go 
back up the steps, one step for each number I count ... 
when I reach three, your eyes will be almost ready to open 
... when I reach two, they will have opened ... and, 
when I reach one, you'll be alert, awake, refreshed ... 
perhaps as though you'd had a nice nap ... alert, re-
freshed, comfortable ... and even though you'll still be 
very comfortable and relaxed, you'll be alert and feeling 
very well ... perhaps surprised, but feeling very well 
... perhaps ready to be surprised .. . . no hurry, you'll 
have all the time you need, as you begin to go back up 
these restful steps ... TWENTY ... NINETEEN ... 
EIGHTEEN ... that's right, feel yourself going back up 
the steps ... ready to be surprised, knowing what you 
had for lunch yesterday, and yet. SEVENTEEN. SIX-
TEEN ... FIFTEEN. a quarter 0£ the way back up, more 
and more alert ... no rush, plenty of time ... feel 
yourself becoming more and more alert ... FOURTEEN ... 
THIRTEEN . . . TWELVE . . . ELEVEN . . . TEN . . . halfway 
back up the stairs ... more and more alert . com-
fortable but more and more alert. NINE that's 
right, feel yourself becoming more and more alert . 
EIGHT . . . SEVEN . . . SIX . . . FIVE . . . FOUR . 
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THREE ... that's right ... TWO ... and ONE .. . 
that's right, wide awake, alert, relaxed, refreshed .. . 
that's fine. How do you feel? Relaxed? Comfortable? 
Since the subject has been given posthypnotic sug-
gestions as part of the initial hypnotic experience, it is 
now possible to elicit an even more satisfactory hypnotic 
state Cinciuding development of analgesia) by utilizing 
one or more of the posthypnotic cues suggested. Whenever 
in the future cues are properly given, the subject rapidly 
and automatically develops a satisfactory hypnotic state 
and is adequately analgesic for clinical procedures. 
